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Brucellosis is a zoonotic disease of important health significance 
in endemic areas such as Iran. Brucellosis can affect any organ or 
system in the human body. Ocular involvement is rare and can lead 
to poor visual prognosis if not treated early. The most common 
ocular manifestation of brucellosis is uveitis, although any ocular 
structure can be involved. The diagnosis of ocular brucellosis is 
based on clinical examination as well as culture and serological 
tests. The classical treatment regimen includes doxycycline and 
rifampin. Early diagnosis and prompt treatment are effective in 
preventing blindness. Here we breifly review the manifestations, 
diagnostic tools, and treatment of ocular brucellosis. 
How to cite this article: Heydar AA, Soleimani M, Soleimani Z. Ocular Brucellosis: A Brief Update. Journal 
of Ophthalmic and Optometric Sciences . 2019;3(1): 30-5.
Journal of Ophthalmic and Optometric Sciences. Volume 3, Number 1, Winter 2019 31
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Introduction
Brucellosis, also known as undulant fever, 
Malta fever, and Mediterranean fever, is 
a zoonotic infection which is prevalent 
worldwide. Brucellosis is mainly transmitted 
from cattle, sheep, goat, pig and camel 
either by direct contact with body fluids of 
infected animals (blood, placenta, fetuses 
or uterine secretions), or through ingesting 
of contaminated raw animal products, such 
as unpasteurized milk and soft cheese 1,2. 
Although brucellosis is nearly eradicated 
in developed countries due to widespread 
livestock vaccination and safe food handling 
procedures; the disease is still endemic in 
the Mediterranean region as a major public 
health concern 1,2. In patients with brucellosis 
any organ or system can be involved 2. The 
symptoms of brucellosis are nonspecific with 
most patients complaining of fever, sweats, 
malaise, headache, arthralgia, and backache 1. 
Ocular involvement is rare and is usually 
a complication of chronic brucellosis 3-5. 
The most common ocular manifestation in 
brucellosis is uveitis; while other findings 
include keratoconjunctivitis, keratitis, 
iridocyclitis, choroiditis, optic neuritis, 
papilledema, and endophthalmitis 4. Despite 
treatment, ocular brucellosis might cause 
severe complications and lead to blindness 4. 
In this manuscript, we present a brief update 
on ocular brucellosis, its manifestations, 
diagnosis, and treatment methods.
Bacteriology
Brucella species are small, aerobic, Gram-
negative coccobacillary, nonmotile, not spore-
forming microorganisms 1. Four species 
have been recognized as causing infection 
in humans: brucella melitensis (transferred 
from goat, sheep, and camel), brucella 
abortus (transferred from cattle), brucella suis 
(transferred from swine) and brucella canis 
(transferred from dogs) 1. Brucella melitensis 
is the most common virulent species (70 % 
of cases). Brucella species grow relatively 
slowly and require 7-21 days to appear using 
the classic biphasic blood cultures 1. Lysis 
centrifugation can detect organisms more 
quickly with higher sensitivity 1. Growth is best 
seen on trypticase soy agar, brucella agar or 
serum dextrose agar at 37 ◦C. Brucella abortus 
and brucella suis require supplementary CO2 
for growth. The incubation period is highly 
variable, usually between 1 and 5 weeks 1.
Epidemiology
The true incidence of brucellosis is unknown 
because most cases remain undiagnosed. The 
World Health Organization (WHO) have 
stated that more than 500,000 new brucellosis 
cases are reported worldwide annually 1,2. 
Brucellosis is still endemic in the Middle East 
countries including Iran, the Mediterranean 
region, Mexico, Central and South America 3-5. 
Brucella melitensis is the most common 
virulent species in endemic countries and 
brucella abortus is mostly reported in Europe 
and North America 3-6. Ocular involvement is 
relatively rare and is reported in 3 % - 26 % of 
cases 3-6. 
Diagnosis
The diagnosis of ophthalmic brucellosis 
might be made clinically through eye 
examination. Ocular brucellosis is suspected 
when eye manifestations are present in a 
patient with fever, sweating, history of animal 
contact in endemic areas and consumption 
of unpasteurized dairy products. Ocular 
brucellosis may be misdiagnosed for years. 
Slit lamp biomicroscopic examination will 
reveal the extent of eye involvement while 
Brucella blood culture will confirm the 
Ocular BrucellosisHeydar et al.
Journal of Ophthalmic and Optometric Sciences. Volume 3, Number 1, Winter 2019
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
32
diagnosis of active systemic brucellosis. 
Culture of aqueous and vitreous samples may 
grow brucella and the brucella agglutinin titer 
may be raised. Serologic techniques such as 
Rose Bengal Plate Test (RBPT) and serum 
agglutination test (SAT) are the most widely 
used serologic tests 7. Polymerase chain 
reaction (PCR) methods are also effective 
in detection of brucellosis 8. The Goldmann-
Witmer coefficient, which is the immune load 
ratio of intraocular to serum IgG production 
against the brucella organism, can help in 
the diagnosis 9-11. B-scan ultrasonography, 
orbital CT scan and MRI might detect any 
abnormalities in the vitreous, choroid, uvea, 
sclera, retina, optic nerve and III, IV and VI 
cranial nerves. 
Clinical Manifestations 
The  clinical  presentations  of  brucellos 
is  include fever, night sweats and joint 
manifestations; though it can be asymptomatic. 
Rarely, multisystem disease with hepatic, 
cardiac, ocular, or central nervous system 
evolvement can be encountered 1. Unfortunately, 
since there is no pathognomonic sign of ocular 
brucellosis, most cases remain undiagnosed 
in endemic countries 12. Considering the poor 
prognosis of undiagnosed ocular brucellosis, 
a high degree of clinical suspicion is of high 
importance, especially in endemic areas. 
Ocular involvement in brucellosis can occur 
both in the acute and chronic phase 4. However, 
as Green 13 reported in 1938, most ocular 
manifestations of brucellosis occur in the 
chronic phase. Although any ocular structure 
might be involved in ocular brucellosis, the 
most frequent ophthalmic manifestation is 
uveitis 5,12,14,15. Studies have reported uveitis 
manifestation in 21 % - 67 % of patients with 
ocular brucellosis 5,9,14. Although the most 
frequent reported type of uveitis is posterior 
uveitis 4, any type can be seen 16. Patients 
with panuveitis will have the worst visual 
outcomes 4, 16. The clinical findings of ocular 
brucellosis include conjunctival injection, 
decreased vision, eye pain, tearing, foreign 
body sensation, diplopia, cotton wool spots, 
exudative retinal detachment, and retinal 
hemorrhage 4,11,17,18.
Rolando et al.,4 reported a large series of 1551 
Peruvian brucellosis patients from 1980 to 
2006 4. Fifty-two patients (3.3 %) had ocular 
brucellosis. Uveitis was present in 82.7 % of 
patients with posterior uveitis (40.3 %) as the 
common form, followed by neuro-ophthalmic 
complications (13 %), keratitis (5.8 %), and 
conjunctivitis (3.8 %) 4. Most patients with eye 
manifestations had chronic brucellosis (86 %) 
and 65 % of patients were females. Bilateral 
ocular involvement was found in 20 patients 
(38.5 %) 4. The poorest prognosis was seen 
among patients with panuveitis sometimes 
leading to blindness or light perception 4. 
Sungur et al., 5 reported ocular manifestations 
of 132 patients with brucellosis from Turkey. 
Ocular involvement was detected in 21 % 
of patients and anterior uveitis was the most 
frequent ocular manifestation (41 %), followed 
by choroiditis (32 %), panuveitis (9 %), 
papilledema (9 %), and retinal hemorrhages 
(9 %). Fifty-nine percent of patients with 
ocular involvement were in the chronic stage of 
brucellosis 5. In contrast to the literature, they 
found that the anterior uveitis manifestation 
was only seen in the acute stage, and all 
posterior segment manifestations were seen in 
the chronic stage of the brucellosis. Güngür et 
al., 3 also, from Turkey, reported a cohort of 147 
patients with brucellosis of which 38 (26 %) 
had ocular manifestations. The most frequent 
ocular findings were conjunctivitis (68.4 %), 
anterior uveitis (15.7 %), episcleritis (7.8 %), 
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dacryoadenitis (5.2 %), and posterior uveitis 
(2.63 %). Seventy-one percent of patients had 
chronic brucellosis 3. Brucellosis might have 
atypical ocular manifestations. Recurrent 
episcleritis associated with brucellosis has 
been reported 19,20. Sahin et al., 21 reported a 
28-year-old female with brucellosis presenting 
with bilateral papillitis, right abducent nerve 
palsy, and premacular hemorrhage. Andisheh 
et al., 22 reported a case of sixth nerve palsy as 
an unusual presentation of neurobrucellosis in 
a young patient. Mete et al., 23 reported a case 
of unilateral brucella dacryoadenitis. Oray et 
al., 24 reported a young female with a 6-month 
history of visual loss in the left eye, presenting 
with dense vitreous haze, posterior hyaloid 
opacities, and retinochoroiditis. The vitreous 
sample demonstrated brucella melitensis 
growth and the patient was diagnosed with 
endogenous endophthalmitis leading to poor 
visual outcome 24. 
Treatment
According to the World Health Organization 
(WHO) guidelines, the classical treatment 
of brucellosis in adults and children above 8 
years is a combination of doxycycline (100 
mg PO twice daily) and rifampin (600-900 
mg/day PO) for 6 weeks 25. Doxycycline for 
6 weeks plus streptomycin (1g/day IM) for 
2-3 weeks is believed to be more effective 
in preventing replace 15. Gentamicin can be 
used as a substitute for streptomycin with 
equal efficacy 26. Ciprofloxacin can also 
replace doxycycline with similar efficacy 25. 
A Cochrane meta-analysis found that 
doxycycline for 6 weeks plus streptomycin 
for 2-3 weeks was more effective than 
doxycycline plus rifampin for 6 weeks 27. 
Tetracyclines are contraindicated in pregnant 
women and children below 8 years 28,29. For 
brucellosis in children younger than 8 years, 
rifampin and TMP-SMZ for 6 weeks is the 
current best therapy 30. Also for brucellosis in 
pregnant women, the recommended therapy is 
rifampin, either alone or in combination with 
TMP-SMZ 31. Note that TMP-SMZ might 
increase the risk of kernicterus at the end of 
pregnancy 31. 
Cavallarro et al., 32 reported a case of bilateral 
papilledema in a child with brucellosis. 
The patient was treated with rifampin and 
minocycline with complete recovery. Abd 
Elrazak 33 successfully treated a 13-year-old 
child with bilateral brucella optic neuritis using 
tetracycline, streptomycin, and prednisolone. 
Sahin et al., 21 reported a case of brucellosis 
complicated by papillitis, gaze palsy, 
endocarditis and premacular hemorrhage. The 
patient underwent surgical replacement of the 
aortic valve and was treated with rifampin 
600 mg/day and doxycycline 200 mg/day for 
6-month with resolution of her symptoms and 
restoration of vision 21. 
Most patients with ocular brucellosis respond 
well to the antibiotic treatment alone. However, 
additional surgical treatments such as abscess 
drainage, cataract extraction and vitrectomy 
may be necessary. Brucellosis complicated 
by panophthalmitis is difficult to treat and 
resistant to classic antibiotic regimens and may 
require ocular enucleation, while optic neuritis 
and ophthalmoparesis due to neurobrucellosis 
usually respond well to antibiotics alone. 
Conclusion
Ophthalmic manifestation of brucellosis is a 
rare entity but should be investigated in all 
patients with brucellosis, especially in endemic 
areas. Uveitis is the most common presentation 
and most cases of ocular involvement present 
in the chronic phase of brucellosis. 
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